PK/PD Modeling for Age-Based Dose Adjustments
PK/PD Modeling for Age-Based Dose Adjustments How PK/PD Modeling Optimizes Dosing Across Age Groups Why Age-Specific PK/PD Modeling Is Critical In drug development, children and older adults are often excluded from early-phase trials. As a result, clinicians rely heavily on modeling and simulation to predict safe and effective doses for these age groups. Pharmacokinetics (PK)…
